SEC Form 4 research
| Issuer | SYNTA PHARMACEUTICALS CORP |
|---|---|
| Tickers | SNTA, MDGL |
| Reporting owners | 59 |
| Officers and directors | 31 |
| Last public filing | 2026-11-06 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-11-06 | 2026-11-06 | 667, L.P., BAKER BROS. ADVISORS LP, BAKER FELIX, BAKER JULIAN, Baker Bros. Advisors (GP) LLC, Baker Brothers Life Sciences LP | P | 2,000 | $396.61 | Not reported |
| 2026-11-06 | 2026-11-06 | 667, L.P., BAKER BROS. ADVISORS LP, BAKER FELIX, BAKER JULIAN, Baker Bros. Advisors (GP) LLC, Baker Brothers Life Sciences LP | P | 13,740 | $388.29 | Not reported |
| 2026-11-06 | 2026-11-06 | 667, L.P., BAKER BROS. ADVISORS LP, BAKER FELIX, BAKER JULIAN, Baker Bros. Advisors (GP) LLC, Baker Brothers Life Sciences LP | P | 60,400 | $383.02 | Not reported |
| 2026-11-06 | 2026-11-04 | 667, L.P., BAKER BROS. ADVISORS LP, BAKER FELIX, BAKER JULIAN, Baker Bros. Advisors (GP) LLC, Baker Brothers Life Sciences LP | P | 10,080 | $368.11 | Not reported |
| 2026-11-06 | 2026-11-04 | 667, L.P., BAKER BROS. ADVISORS LP, BAKER FELIX, BAKER JULIAN, Baker Bros. Advisors (GP) LLC, Baker Brothers Life Sciences LP | P | 5,586 | $366.99 | Not reported |
| 2026-11-06 | 2026-11-06 | Kelley Shannon T | S | 1,077 | $400 | Not reported |
| 2026-09-11 | 2026-09-09 | Sibold William John | S | 640 | $537.17 | Not reported |
| 2026-09-11 | 2026-09-09 | Sibold William John | S | 1,040 | $536.11 | Not reported |
| 2026-09-11 | 2026-09-09 | Sibold William John | S | 644 | $535.27 | Not reported |
| 2026-09-11 | 2026-09-09 | Sibold William John | S | 396 | $534.2 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.